Literature DB >> 16061560

Directly transmitted unbalanced chromosome abnormalities and euchromatic variants.

J C K Barber1.   

Abstract

In total, 200 families were reviewed with directly transmitted, cytogenetically visible unbalanced chromosome abnormalities (UBCAs) or euchromatic variants (EVs). Both the 130 UBCA and 70 EV families were divided into three groups depending on the presence or absence of an abnormal phenotype in parents and offspring. No detectable phenotypic effect was evident in 23/130 (18%) UBCA families ascertained mostly through prenatal diagnosis (group 1). In 30/130 (23%) families, the affected proband had the same UBCA as other phenotypically normal family members (group 2). In the remaining 77/130 (59%) families, UBCAs had consistently mild consequences (group 3). In the 70 families with established EVs of 8p23.1, 9p12, 9q12, 15q11.2, and 16p11.2, no phenotypic effect was apparent in 38/70 (54%). The same EV was found in affected probands and phenotypically normal family members in 30/70 families (43%) (group 2), and an EV co-segregated with mild phenotypic anomalies in only 2/70 (3%) families (group 3). Recent evidence indicates that EVs involve copy number variation of common paralogous gene and pseudogene sequences that are polymorphic in the normal population and only become visible at the cytogenetic level when copy number is high. The average size of the deletions and duplications in all three groups of UBCAs was close to 10 Mb, and these UBCAs and EVs form the "Chromosome Anomaly Collection" at http://www.ngrl.org.uk/Wessex/collection. The continuum of severity associated with UBCAs and the variability of the genome at the sub-cytogenetic level make further close collaboration between medical and laboratory staff essential to distinguish clinically silent variation from pathogenic rearrangement.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16061560      PMCID: PMC1736115          DOI: 10.1136/jmg.2004.026955

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  170 in total

1.  A transmitted deletion of 2q13 to 2q14.1 causes no phenotypic abnormalities.

Authors:  N D Sumption; J C Barber
Journal:  J Med Genet       Date:  2001-02       Impact factor: 6.318

2.  Inherited duplication, dup (8) (p23.1p23.1) pat, in a father and daughter with congenital heart defects.

Authors:  S J Kennedy; A S Teebi; I Adatia; I Teshima
Journal:  Am J Med Genet       Date:  2001-11-15

3.  Characterization of a heritable partial monosomy 18p by molecular and cytogenetic analysis.

Authors:  M A Rigola; A Plaja; C Mediano; R Miró; J Egozcue; C Fuster
Journal:  Am J Med Genet       Date:  2001-11-15

4.  Direct duplication of 8p21.3-->p23.1: a cytogenetic anomaly associated with developmental delay without consistent clinical features.

Authors:  Y S Fan; V M Siu; J H Jung; S A Farrell; G B Côté
Journal:  Am J Med Genet       Date:  2001-10-15

5.  High resolution comparative genomic hybridisation in clinical cytogenetics.

Authors:  M Kirchhoff; H Rose; C Lundsteen
Journal:  J Med Genet       Date:  2001-11       Impact factor: 6.318

6.  Mother to son transmission of del(1) (q42.1q42.3).

Authors:  J A Sanford Hanna; S Ball; R A Pagon; M Donlan
Journal:  Am J Med Genet       Date:  2001-01-01

7.  Constitutional genomic instability with inversions, duplications, and amplifications in 9p23-24 in BRCA2 mutation carriers.

Authors:  L Savelyeva; A Claas; I Matzner; P Schlag; W Hofmann; S Scherneck; B Weber; M Schwab
Journal:  Cancer Res       Date:  2001-07-01       Impact factor: 12.701

8.  Monosomy for the most telomeric, gene-rich region of the short arm of human chromosome 16 causes minimal phenotypic effects.

Authors:  S W Horsley; R J Daniels; E Anguita; H A Raynham; J F Peden; A Villegas; M A Vickers; S Green; J S Waye; D H Chui; H Ayyub; A B MacCarthy; V J Buckle; R J Gibbons; L Kearney; D R Higgs
Journal:  Eur J Hum Genet       Date:  2001-03       Impact factor: 4.246

9.  Autism or atypical autism in maternally but not paternally derived proximal 15q duplication.

Authors:  E H Cook; V Lindgren; B L Leventhal; R Courchesne; A Lincoln; C Shulman; C Lord; E Courchesne
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

10.  Submicroscopic terminal deletions and duplications in retarded patients with unclassified malformation syndromes.

Authors:  M Riegel; A Baumer; M Jamar; K Delbecque; C Herens; A Verloes; A Schinzel
Journal:  Hum Genet       Date:  2001-09       Impact factor: 4.132

View more
  38 in total

1.  The euchromatic 9p+ polymorphism is a locus-specific amplification caused by repeated copies of a small DNA segment mapping within 9p12.

Authors:  Rosetta Lecce; Marina Murdolo; Gianfranco Gelli; Katharina Steindl; Livia Coppola; Anna Romano; Elisa Cupelli; Giovanni Neri; Marcella Zollino
Journal:  Hum Genet       Date:  2005-12-02       Impact factor: 4.132

2.  Genomic characterization of prenatally detected chromosomal structural abnormalities using oligonucleotide array comparative genomic hybridization.

Authors:  Peining Li; Pawel Pomianowski; Miriam S DiMaio; Joanne R Florio; Michael R Rossi; Bixia Xiang; Fang Xu; Hui Yang; Qian Geng; Jiansheng Xie; Maurice J Mahoney
Journal:  Am J Med Genet A       Date:  2011-06-10       Impact factor: 2.802

3.  Study of structural chromosome abnormalities to increase the understanding of human genetic diversity: a commentary on signature of backward replication slippage at the copy number variation junction.

Authors:  Keiko Wakui
Journal:  J Hum Genet       Date:  2014-10-09       Impact factor: 3.172

4.  Whole-exome sequence analysis highlights the role of unmasked recessive mutations in copy number variants with incomplete penetrance.

Authors:  Matthieu Egloff; Lam-Son Nguyen; Karine Siquier-Pernet; Valérie Cormier-Daire; Geneviève Baujat; Tania Attié-Bitach; Christine Bole-Feysot; Patrick Nitschke; Michel Vekemans; Laurence Colleaux; Valérie Malan
Journal:  Eur J Hum Genet       Date:  2018-02-26       Impact factor: 4.246

5.  16p11.2-p12.2 duplication syndrome; a genomic condition differentiated from euchromatic variation of 16p11.2.

Authors:  John C K Barber; Victoria Hall; Viv K Maloney; Shuwen Huang; Angharad M Roberts; Angela F Brady; Nicki Foulds; Beverley Bewes; Marianne Volleth; Thomas Liehr; Karl Mehnert; Mark Bateman; Helen White
Journal:  Eur J Hum Genet       Date:  2012-07-25       Impact factor: 4.246

6.  De novo 15.5-Mb Interstitial Deletion in 5p in a Male Ascertained by Oligospermia.

Authors:  I Papoulidis; A Vetro; K Kefalas; S Orru; L Thomaidis; Z Iliodromiti; O Zuffardi; E Manolakos
Journal:  Mol Syndromol       Date:  2013-06-12

Review 7.  Unveiling Human Non-Random Genome Editing Mechanisms Activated in Response to Chronic Environmental Changes: I. Where Might These Mechanisms Come from and What Might They Have Led To?

Authors:  Loris Zamai
Journal:  Cells       Date:  2020-10-27       Impact factor: 6.600

8.  Recurrent copy number changes in mentally retarded children harbour genes involved in cellular localization and the glutamate receptor complex.

Authors:  Martin Poot; Marc J Eleveld; Ruben van 't Slot; Hans Kristian Ploos van Amstel; Ron Hochstenbach
Journal:  Eur J Hum Genet       Date:  2010-01       Impact factor: 4.246

9.  Multiple Small Supernumerary Marker Chromosomes Resulting from Maternal Meiosis I or II Errors.

Authors:  Ron Hochstenbach; Beata Nowakowska; Marianne Volleth; Amber Ummels; Anna Kutkowska-Kaźmierczak; Ewa Obersztyn; Kamila Ziemkiewicz; Claudia Gerloff; Denny Schanze; Martin Zenker; Petra Muschke; Ina Schanze; Martin Poot; Thomas Liehr
Journal:  Mol Syndromol       Date:  2015-10-31

10.  Autosomal-dominant microtia linked to five tandem copies of a copy-number-variable region at chromosome 4p16.

Authors:  Irina Balikova; Kevin Martens; Cindy Melotte; Mustapha Amyere; Steven Van Vooren; Yves Moreau; David Vetrie; Heike Fiegler; Nigel P Carter; Thomas Liehr; Miikka Vikkula; Gert Matthijs; Jean-Pierre Fryns; Ingele Casteels; Koen Devriendt; Joris Robert Vermeesch
Journal:  Am J Hum Genet       Date:  2008-01       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.